Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epicardial adipose tissue as a metabolic transducer: role in heart failure and coronary artery disease
Vaibhav B. Patel, Saumya Shah, Subodh Verma, et al.
Heart Failure Reviews (2017) Vol. 22, Iss. 6, pp. 889-902
Closed Access | Times Cited: 191

Showing 1-25 of 191 citing articles:

Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System
Mahmoud Gheblawi, Kaiming Wang, Anissa Viveiros, et al.
Circulation Research (2020) Vol. 126, Iss. 10, pp. 1456-1474
Open Access | Times Cited: 1785
SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review
Subodh Verma, John J.V. McMurray
Diabetologia (2018) Vol. 61, Iss. 10, pp. 2108-2117
Open Access | Times Cited: 790
Epicardial Adipose Tissue May Mediate Deleterious Effects of Obesity and Inflammation on the Myocardium
Milton Packer
Journal of the American College of Cardiology (2018) Vol. 71, Iss. 20, pp. 2360-2372
Closed Access | Times Cited: 477
Effects of SGLT2 Inhibitors on Kidney and Cardiovascular Function
Volker Vallon, Subodh Verma
Annual Review of Physiology (2020) Vol. 83, Iss. 1, pp. 503-528
Open Access | Times Cited: 322
The renin-angiotensin system: going beyond the classical paradigms
Robson A.S. Santos, Gavin Y. Oudit, Thiago Verano‐Braga, et al.
AJP Heart and Circulatory Physiology (2019) Vol. 316, Iss. 5, pp. H958-H970
Open Access | Times Cited: 283
Evaluation of the effect of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR‐Reduced trial
Milton Packer, Javed Butler, Gerasimos Filippatos, et al.
European Journal of Heart Failure (2019) Vol. 21, Iss. 10, pp. 1270-1278
Open Access | Times Cited: 251
Evaluation of the effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR‐Preserved Trial
Stefan D. Anker, Javed Butler, Gerasimos Filippatos, et al.
European Journal of Heart Failure (2019) Vol. 21, Iss. 10, pp. 1279-1287
Open Access | Times Cited: 223
The clinical potential of circulating microRNAs in obesity
Chenbo Ji, Xirong Guo
Nature Reviews Endocrinology (2019) Vol. 15, Iss. 12, pp. 731-743
Closed Access | Times Cited: 222
Epicardial adipose tissue and cardiovascular diseases
Anna Maria Ansaldo, Fabrizio Montecucco, Amirhossein Sahebkar, et al.
International Journal of Cardiology (2018) Vol. 278, pp. 254-260
Closed Access | Times Cited: 197
SGLT2i: beyond the glucose-lowering effect
Lihua Ni, Yuan Cheng, Guopeng Chen, et al.
Cardiovascular Diabetology (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 176
Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis
Gregory Livshits, Alexander Kalinkovich
Ageing Research Reviews (2019) Vol. 56, pp. 100980-100980
Closed Access | Times Cited: 174
Impact of different ectopic fat depots on cardiovascular and metabolic diseases
Daniele Ferrara, Fabrizio Montecucco, Franco Dallegri, et al.
Journal of Cellular Physiology (2019) Vol. 234, Iss. 12, pp. 21630-21641
Closed Access | Times Cited: 160
The Role of the Epicardium During Heart Development and Repair
Pearl Quijada, Michael A. Trembley, Eric M. Small
Circulation Research (2020) Vol. 126, Iss. 3, pp. 377-394
Open Access | Times Cited: 156
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors
Teresa Salvatore, Raffaele Galiero, Alfredo Caturano, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3651-3651
Open Access | Times Cited: 145
Dapagliflozin for heart failure according to body mass index: the DELIVER trial
Carly Adamson, Toru Kondo, Pardeep S. Jhund, et al.
European Heart Journal (2022) Vol. 43, Iss. 41, pp. 4406-4417
Open Access | Times Cited: 93
Inflammation in Obesity-Related HFpEF
Subodh Verma, Mark C. Petrie, Barry A. Borlaug, et al.
Journal of the American College of Cardiology (2024) Vol. 84, Iss. 17, pp. 1646-1662
Open Access | Times Cited: 16
Physical Activity, Fitness, and Obesity in Heart Failure With Preserved Ejection Fraction
Ambarish Pandey, Kershaw V. Patel, Muthiah Vaduganathan, et al.
JACC Heart Failure (2018) Vol. 6, Iss. 12, pp. 975-982
Open Access | Times Cited: 160
Obesity-Related Heart Failure With a Preserved Ejection Fraction
Milton Packer, Dalane W. Kitzman
JACC Heart Failure (2018) Vol. 6, Iss. 8, pp. 633-639
Open Access | Times Cited: 135
SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management
Lin Wu, Aislinn M. O'Kane, Peng Hu, et al.
Biochemical Pharmacology (2020) Vol. 178, pp. 114114-114114
Open Access | Times Cited: 125
Impact of Epicardial Adipose Tissue, Left Ventricular Myocardial Fat Content, and Interstitial Fibrosis on Myocardial Contractile Function
Arnold C.T. Ng, Mark Strudwick, Rob J. van der Geest, et al.
Circulation Cardiovascular Imaging (2018) Vol. 11, Iss. 8
Closed Access | Times Cited: 113
Myocardial adipose deposition and the development of heart failure with preserved ejection fraction
Cho‐Kai Wu, Jen‐Kuang Lee, Jung‐Chi Hsu, et al.
European Journal of Heart Failure (2019) Vol. 22, Iss. 3, pp. 445-454
Open Access | Times Cited: 109
Adipokines and Inflammation: Focus on Cardiovascular Diseases
Sandra Feijóo‐Bandín, Alana Aragón‐Herrera, Sandra Moraña‐Fernández, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7711-7711
Open Access | Times Cited: 78
Epicardial Adipose Tissue and Cardiovascular Disease
Thierry H. Le Jemtel, Rohan Samson, Karnika Ayinapudi, et al.
Current Hypertension Reports (2019) Vol. 21, Iss. 5
Closed Access | Times Cited: 77
SGLT2 Inhibitors and Their Mode of Action in Heart Failure—Has the Mystery Been Unravelled?
Steffen Pabel, Nazha Hamdani, Mark Luedde, et al.
Current Heart Failure Reports (2021) Vol. 18, Iss. 5, pp. 315-328
Open Access | Times Cited: 76
Inflammation in Metabolic Cardiomyopathy
Florian A. Wenzl, Samuele Ambrosini, S A Mohammed, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 69
Page 1 - Next Page

Scroll to top